Medicinski Kisik Istrabenz Plini (Oxygen)

Medicinski Kisik Istrabenz Plini provides supplemental oxygen and is used in conditions where increased oxygen delivery is required.

• Hypoxemia: restores adequate arterial oxygen levels to prevent tissue hypoxia.
• Respiratory distress: improves breathing efficiency and reduces work of breathing.
• Cardiac arrest: supports vital organ oxygenation during resuscitation efforts.
• Post‑operative oxygen support: maintains optimal oxygen saturation during recovery.

• Oxygen delivered via inhalation diffuses across the alveolar membrane into the pulmonary capillary blood, raising the partial pressure of arterial oxygen (PaO2). The increased PaO2 enhances hemoglobin saturation and dissolves more O2 in plasma, thereby improving tissue oxygen delivery and supporting cellular respiration, especially in organs with high metabolic demand. This physiological effect helps to correct hypoxemia, reduce anaerobic metabolism, and stabilize vital signs in acute care settings.

Oxygen therapy may be associated with both common and serious adverse reactions.

Common Side Effects

• Nasal dryness or irritation
• Headache
• Drowsiness or fatigue
• Cough

Serious or Rare Side Effects

• Pulmonary oxygen toxicity leading to inflammation
• Central nervous system toxicity causing seizures
• Fire hazard when used near open flames
• Retinopathy of prematurity in neonates (high concentration)

When using Medicinski Kisik Istrabenz Plini, several precautions should be observed to ensure safety and efficacy.

• Assess patient oxygen saturation: verify need for supplemental oxygen before initiation.
• Use lowest effective concentration: titrate flow to maintain target SpO2.
• Monitor for signs of hyperoxia: watch for respiratory depression or oxygen toxicity.
• Avoid use in patients with CO2 retention without monitoring: risk of hypoventilation.
• Keep away from ignition sources: oxygen supports combustion.
• Store at ambient temperature: keep cylinders in a well‑ventilated area, protect from heat and direct sunlight.

Oxygen can interact with certain agents, altering safety or efficacy.

Major Interactions (Avoid)

• Nitrous oxide: combined use increases fire risk.
• Flammable anesthetic gases (e.g., ether): heightened combustion hazard.
• Certain chemotherapeutic agents (e.g., bleomycin): may exacerbate pulmonary toxicity.

Moderate Interactions (Monitor Closely)

• Opioids and sedatives: additive respiratory depression risk.
• Bronchodilators (e.g., β2‑agonists): may enhance oxygen uptake, requiring dose adjustment.
• Carbon monoxide exposure: high oxygen may mask hypoxia signs.